A Study to Evaluate Unintended Prolonged Opioid Use
NCT04024397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1796
Last updated 2024-03-27
Summary
Researchers are trying to better understand how people who are prescribed opioids for short-term use, go on to receive this type of medication on a longer-term basis.
Conditions
- Opioid Use
Sponsors & Collaborators
-
National Center for Advancing Translational Sciences (NCATS)
collaborator NIH - lead OTHER
Principal Investigators
-
W. Michael Hooten, MD · Mayo Clinic
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2019-10-01
- Primary Completion
- 2023-12-01
- Completion
- 2023-12-29
Countries
- United States
Study Locations
More Related Trials
-
Opioid Rotation From Morphine to Methadone in Treatment of Non-malignant Pain
NCT00356083 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamics and Arteriovenous Differences of Naloxone in Healthy Participants Exposed to an Opioid
NCT02405988 ·Status: COMPLETED ·Phase: NA
-
Reversal of Opioid-induced Respiratory Depression With Opioid Antagonists
NCT05338632 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.
NCT03389750 ·Status: COMPLETED ·Phase: PHASE2
-
Health Outcomes From Opioid Therapy for Chronic Pain
NCT00495404 ·Status: COMPLETED ·Phase: NA
-
Prescription Opioid Effects in Abusers Versus Non-Abusers
NCT00158184 ·Status: COMPLETED ·Phase: PHASE2
-
Determining the Feasibility of Outpatient Parenteral Antibiotic Therapy for Persons Who Inject Opioids
NCT05300581 ·Status: COMPLETED ·Phase: NA
-
Assessing Abuse Potential of Parenteral Buprenorphine/Naloxone in Non-Dependent Opioid Abusers
NCT00134875 ·Status: TERMINATED ·Phase: NA
-
Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence
NCT00134888 ·Status: COMPLETED ·Phase: NA
-
Primary Care Intervention to Reduce Prescription Opioid Overdoses
NCT02464410 ·Status: COMPLETED ·Phase: NA
-
Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9
NCT00000344 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacodynamic Evaluation of Intranasal Nalmefene
NCT04828005 ·Status: COMPLETED ·Phase: PHASE1
-
Guiding Aging Long-Term Opioid Therapy Users Into Safer Use Patterns
NCT05808127 ·Status: COMPLETED ·Phase: NA
-
Aprepitant Effects on Oxycodone Response
NCT00999544 ·Status: COMPLETED ·Phase: NA
-
Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence
NCT00134914 ·Status: COMPLETED ·Phase: NA
-
Effects of Buprenorphine and Naloxone in Opiate Addicts - 4
NCT00000355 ·Status: COMPLETED ·Phase: PHASE1
-
Buprenorphine Dose Alteration Study - 1
NCT00000219 ·Status: COMPLETED ·Phase: PHASE1
-
A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain
NCT01971632 ·Status: COMPLETED ·Phase: PHASE3
-
Neurobiology of Opioid Dependence: 4 - 4
NCT00000195 ·Status: WITHDRAWN ·Phase: PHASE2
-
Low-dose Buprenorphine Initiation for Opioid Use Disorder
NCT05450718 ·Status: RECRUITING ·Phase: PHASE4
-
User Acceptability of a Device-Based Opioid Overdose Intervention
NCT04530591 ·Status: COMPLETED
-
Open Label Placebo to Reduce Prescription Opioid Use
NCT05014230 ·Status: UNKNOWN ·Phase: NA
-
Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse
NCT01967641 ·Status: COMPLETED ·Phase: PHASE2
-
Opioid Physiology Project
NCT03462797 ·Status: COMPLETED
-
Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2
NCT00000299 ·Status: COMPLETED ·Phase: PHASE2